HCW Biologics Inc. Property, Plant and Equipment
HCW Biologics Inc. (HCWB) had Property, Plant and Equipment of $20.75 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-14
- 2026-06-30: Property, Plant and Equipment, Net $20.75M.
- 2026-03-31: Property, Plant and Equipment, Net $20.77M.
- 2025-12-31: Property, Plant and Equipment, Net $20.88M.
- 2025-09-30: Property, Plant and Equipment, Net $22.50M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $20.75M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $20.77M 10-Q/A · filed 2026-08-14 | |
| 2025-12-31 | $20.88M 10-Q/A · filed 2026-08-14 | |
| 2025-09-30 | $22.50M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $22.64M 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $22.76M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $22.91M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $22.83M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $22.81M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $22.59M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $20.45M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $14.78M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $12.62M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $11.74M 10-Q/A · filed 2023-08-10 | |
| 2022-12-31 | $10.80M 10-K/A · filed 2024-05-15 | |
| 2022-09-30 | $10.96M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $913.73K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.01M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.12M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $1.27M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.39M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $1.62M 10-K · filed 2022-03-29 | $1.65M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |